SCHEMBL23309511

SCHEMBL23309511

CCOc1cccc(NC(=O)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ PLAU P00749 1/20 0.52
▸ NR1H4 Q96RI1 1/20 0.51
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ FADS1 O60427 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ HTT P42858 2/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ RECQL P46063 1/20 0.48
▸ LMNA P02545 3/20 0.48
▸ KCNK3 O14649 2/20 0.48
▸ KCNK9 Q9NPC2 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309584 0.87 NPC1 (0.57) KMT2ASMN1; SMN2NPC1RAB9APOLB
SCHEMBL23309513 0.87 RAB9A (0.63) KMT2ASMN1; SMN2NPC1RAB9APOLB
SCHEMBL23309593 0.86 GRM4 (0.52) KMT2ASMN1; SMN2PLAUNPC1RAB9A
SCHEMBL23309612 0.84 GRM4 (0.47) SMN1; SMN2NPC1RAB9APOLBHTT
SCHEMBL23309585 0.83 KDM4E (0.52) KMT2ASMN1; SMN2PLAUNR1H4NPC1
SCHEMBL23309615 0.82 P2RX1 (0.58) NPC1RAB9AHTTKCNK3KCNK9
SCHEMBL23309589 0.82 RAB9A (0.63) KMT2ASMN1; SMN2NPC1RAB9APOLB
SCHEMBL23309536 0.80 MEN1 (0.55) KMT2ASMN1; SMN2NPC1RAB9AHSD17B10
SCHEMBL23309490 0.78 GAA (0.51) KMT2ASMN1; SMN2NPC1RAB9APOLB
SCHEMBL23309548 0.78 FADS1 (0.55) KMT2ASMN1; SMN2NPC1RAB9AFADS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL KMT2A 2360/4885SMN1; SMN2 3893/4885PLAU 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback